ALKERMES | ALKS - 이자 수익





이자 수익 변화 날짜
AbbVie USD 72M 13M 2026-03
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
ALKERMES USD 8.54M 3.59M 2026-03
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 0 2026-03
Heron Therapeutics USD 433K 277K 2021-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.27 0.13 2026-06
Merck USD 35M 34M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
Otsuka Holdings JPY 10.49B 396M 2024-06
Pfizer USD -0.04 115M 2026-06
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06